Page last updated: 2024-08-21

2-piperidone and Small Cell Lung Carcinoma

2-piperidone has been researched along with Small Cell Lung Carcinoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bergqvist, M; Bergström, S; Ekman, S; Gullbo, J; Lennartsson, J; Sooman, L1
Danishefsky, SJ; Downey, R; Lecomte, N; Moore, MA; Nagorny, P; Njardarson, JT; Ouerfelli, O; Yang, G1

Other Studies

2 other study(ies) available for 2-piperidone and Small Cell Lung Carcinoma

ArticleYear
Synergistic effects of combining proteasome inhibitors with chemotherapeutic drugs in lung cancer cells.
    BMC research notes, 2017, Nov-02, Volume: 10, Issue:1

    Topics: Adenocarcinoma; Antineoplastic Agents; Bortezomib; Carcinoma, Non-Small-Cell Lung; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Deoxycytidine; Drug Therapy, Combination; Gefitinib; Gemcitabine; Humans; Piperidones; Proteasome Inhibitors; Quinazolines; Small Cell Lung Carcinoma; Vinblastine; Vinorelbine

2017
Emergence of potent inhibitors of metastasis in lung cancer via syntheses based on migrastatin.
    Proceedings of the National Academy of Sciences of the United States of America, 2011, Sep-13, Volume: 108, Issue:37

    Topics: Animals; Cell Line, Tumor; Cell Movement; Ethers; Humans; Lung Neoplasms; Macrolides; Male; Mice; Neoplasm Metastasis; Piperidones; Small Cell Lung Carcinoma; Xenograft Model Antitumor Assays

2011